Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Safety and Efficacy of PDP-716

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Be male or female, of 2 years of age or older~2. Have open-angle glaucoma or ocular hypertension in both the eyes~3. Be able and willing to follow study instructions and complete all required visits.~Exclusion Criteria:~1. Females who are pregnant/lactating.~2. Have uncontrolled systemic disease which might interfere with the study~3. Any known allergy or sensitivity to the study medications or their components~4. Any other clinically relevant abnormality

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PDP-716 (Type: EXPERIMENTAL): None
- Brimonidine Tartrate Ophthalmic Solution (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).